Literature DB >> 16310560

Urinary tract infections-microbial virulence determinants and reactive oxygen species.

G Rama1, D K Chhina, R S Chhina, S Sharma.   

Abstract

The human urinary tract is able to combat with the microbial invasion under normal circumstances. To cause urinary tract infection the organism has to evade the host defense mechanisms by possessing distinct properties which contribute to the virulence of the organism hence called virulence determinants Ninety percent of uncomplicated urinary tract infections are caused by Escherichia coli, hence the knowledge of the virulence determinants of this organism can be extrapolated to other uropathogenic organism as well. Virulence determinants of uropathogenic E. coli include adhesins, siderophore production, polysaccharide coating, hemolysin production, outer membrane proteins etc. The intestinal E. coli, which are the reservoir of E. coli for causing UTI, lack these virulence determinants. On the other hand these virulence determinants enable the organism to colonize and invade the urinary tract. In addition these are important in acquiring the nutrients in other wise nutrient deficient environment. Further, they also help the organisms in triggering an inflammatory response and hence bringing about pathological changes which leads to symptomatic UTI. Severity of symptomatic infections and tissue damage during the infective process depends upon the magnitude of the inflammatory response triggered by the uropathogen which in turn is dependent upon the amount of extrcellular release of reactive oxygen species by the phagocytic cells; hence role of antioxidants as an adjunct to antibiotics in the treatment of infective process needs to be evaluated further.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16310560     DOI: 10.1016/j.cimid.2005.09.002

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  8 in total

Review 1.  The multiple antibacterial activities of the bladder epithelium.

Authors:  Jianxuan Wu; Yuxuan Miao; Soman N Abraham
Journal:  Ann Transl Med       Date:  2017-01

Review 2.  Immunity to uropathogens: the emerging roles of inflammasomes.

Authors:  Claire Hamilton; Lionel Tan; Thomas Miethke; Paras K Anand
Journal:  Nat Rev Urol       Date:  2017-03-07       Impact factor: 14.432

3.  Transfer of noncoding DNA drives regulatory rewiring in bacteria.

Authors:  Yaara Oren; Mark B Smith; Nathan I Johns; Millie Kaplan Zeevi; Dvora Biran; Eliora Z Ron; Jukka Corander; Harris H Wang; Eric J Alm; Tal Pupko
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

4.  Impact of the RNA chaperone Hfq on the fitness and virulence potential of uropathogenic Escherichia coli.

Authors:  Richard R Kulesus; Karen Diaz-Perez; E Susan Slechta; Danelle S Eto; Matthew A Mulvey
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

5.  The NACHT, LRR and PYD Domains-Containing Protein 3 (NLRP3) Inflammasome Mediates Inflammation and Voiding Dysfunction in a Lipopolysaccharide-Induced Rat Model of Cystitis.

Authors:  Francis M Hughes; James G Kennis; Melissa N Youssef; Danielle W Lowe; Brooke E Shaner; J Todd Purves
Journal:  J Clin Cell Immunol       Date:  2016-02-29

6.  (CGG)4-based PCR as a novel tool for discrimination of uropathogenic Escherichia coli strains: comparison with enterobacterial repetitive intergenic consensus-PCR.

Authors:  Wioletta Adamus-Bialek; Arkadiusz Wojtasik; Marta Majchrzak; Marek Sosnowski; Pawel Parniewski
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

7.  Small Non-coding RNA RyhB Mediates Persistence to Multiple Antibiotics and Stresses in Uropathogenic Escherichia coli by Reducing Cellular Metabolism.

Authors:  Shanshan Zhang; Shuang Liu; Nan Wu; Youhua Yuan; Wenhong Zhang; Ying Zhang
Journal:  Front Microbiol       Date:  2018-02-06       Impact factor: 5.640

8.  RpoS contributes to phagocyte oxidase-mediated stress resistance during urinary tract infection by Escherichia coli CFT073.

Authors:  Andrew J Hryckowian; Rodney A Welch
Journal:  MBio       Date:  2013-02-12       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.